AGC
Anna Gabriella Chagas Antici Portfolio
Invests via Ace Management Global Ltd. | Managed by Anna Gabriella Chagas Antici
Invests via Ace Management Global Ltd.
Managed by Anna Gabriella Chagas Antici
Automatically Tracked
Anna Gabriella Chagas Antici Profile
Seasoned entrepreneur and investor focused on early-stage technology and fintech companies, Anna Gabriella Chagas Antici combines operating experience with angel and seed-stage investing. She has led product, growth and strategic partnerships at startups and has sat on boards advising scaling teams. Market-relevant strengths include deal sourcing, operator-led due diligence, and growth strategy; capital focus centers on Series A and pre-Series A opportunities in digital platforms and financial services.
Seasoned entrepreneur and investor focused on early-stage technology and fintech companies, Anna Gabriella Chagas Antici combines operating experience with angel and seed-stage investing. She has led product, growth and strategic partnerships at startups and has sat on boards advising scaling teams. Market-relevant strengths include deal sourcing, operator-led due diligence, and growth strategy; capital focus centers on Series A and pre-Series A opportunities in digital platforms and financial services.
Investment Philosophy & Strategy
Operator-led investor focused on pre-seed through Series A fintech and digital platform opportunities, deploying capital to teams with defensible product-market fit and clear growth levers. Emphasizes thesis-driven, founder-aligned allocations, active board or strategic partnership roles, and rapid validation milestones to de-risk early exposure. Prefers repeatable unit economics, network-enabled distribution, and concentrated bets paired with hands-on growth support and 3–7 year exit horizons.
Operator-led investor focused on pre-seed through Series A fintech and digital platform opportunities, deploying capital to teams with defensible product-market fit and clear growth levers. Emphasizes thesis-driven, founder-aligned allocations, active board or strategic partnership roles, and rapid validation milestones to de-risk early exposure. Prefers repeatable unit economics, network-enabled distribution, and concentrated bets paired with hands-on growth support and 3–7 year exit horizons.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
4.29%
Gain -0.08%
Monthly
0.35%
Yearly
4.29%
Drawdown
20.88%
$0
Equity
Holdings
$0
Investment
$0
$10.49M
Profit -$234,654.48
Realized
$10.49M
Unrealized
$0
Dividends
$1.03M
Goals
Avg. 47.5% completed goals
Yearly
Gain > 5% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
-0.08%
Profit
-$234,654.48
Win %
100%
This Week
Compared To Last Week
Gain
-1.37%
Profit
-$108,265.38
Win %
100%
This Month
Compared to last month
Gain
-13.36%
Profit
-$1.2M
Win %
100%
This Year
Compared to last year
Gain
-1.06%
Profit
-$83,464.5
Win %
100%
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 17 | Longs Won 6/17 35% | Profit Factor 1.66 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $4.7M |
| Average Win $4.42M | Best Trade (Dec 31) $16.93M | Sharpe Ratio -15.28 |
| Average Loss -$1.45M | Worst Trade (Dec 30) -$4.03M | Z-Score 2.06 (96.08%) |
| Commissions $0 | Avg. Trade Length 5m 3w 6d | Expectancy $617,049.25 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
FAQ
Which stocks have generated the highest profits for Anna Gabriella Chagas Antici?
The largest contributions to the portfolio's profits come from the following stocks: Masimo Corporation - $14.26M, Danaher Corporation - $4.9M, Eaton Corporation plc - $2.56M, and SPDR S&P 500 ETF Trust - $1.83M. These positions have been the main drivers of growth and have significantly impacted the investor's overall performance.
Which stocks have generated the largest losses for this investor?
The largest losses in the portfolio are associated with the following stocks: Alphabet Inc - $3.93M, ASML Holding N.V. New York Registry Shares - $3.36M, Nextracker Inc - $2.35M, Microsoft Corp - $1.54M, and Schlumberger Limited - $553,985.84. These positions have had the most negative impact on overall performance and highlight the weaker areas of the portfolio.
What dividends does Anna Gabriella Chagas Antici's portfolio generate?
The portfolio generates substantial dividend income, with a total of $1.03M earned over time. The largest contributors to dividend income include Eaton Corporation plc - $243,886.76, SPDR S&P 500 ETF Trust - $198,065.54, Microsoft Corp - $161,940.52, Danaher Corporation - $136,475.28, and Alphabet Inc - $98,813.2. This indicates that dividends play a meaningful role in the investor's overall strategy.
How stable are Anna Gabriella Chagas Antici's monthly returns?
Anna Gabriella Chagas Antici's monthly returns appear quite volatile. The gap between stronger and weaker months is meaningful, which suggests that the strategy can experience noticeable swings over relatively short periods. For users assessing this profile, that usually means returns may be attractive over time, but the path can be uneven and harder to tolerate during weaker periods.
Can Anna Gabriella Chagas Antici's strategy be considered aggressive or moderate?
It is difficult to clearly classify Anna Gabriella Chagas Antici's strategy as aggressive or moderate based on the available data. A more complete performance and portfolio structure history would be needed to assess the overall risk profile with confidence.
Should beginners follow Anna Gabriella Chagas Antici's strategy?
It is difficult to determine whether Anna Gabriella Chagas Antici's strategy is suitable for beginners based on the available data. A more complete view of performance, risk, and portfolio structure would be needed for a confident assessment.
